Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02435849
Title Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
Acronym ELIANA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT | AUS

Facility Status City State Zip Country Details
Childrens Hospital Los Angeles SC CTL019 Los Angeles California 90027 United States Details
Stanford Universtiy Medical Center SC - CTL019B2205J - B2206 Stanford California 94304 United States Details
Children's Healthcare of Atlanta SC CTL019 Atlanta Georgia 30342 United States Details
University of Michigan . Ann Arbor Michigan 48109-2800 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Children s Mercy Hospital SC - CTL019B2205J Kansas City Missouri 64108 United States Details
Duke Unversity Medical Center . Durham North Carolina 27705 United States Details
Oregon Health and Science University Doernbecher Children's Hosp. Portland Oregon 97239-3098 United States Details
The Childrens Hospital of Philadelphia CHOP Philadelphia Pennsylvania 19104 United States Details
University of Texas Southwestern Medical Center . Dallas Texas 75235 United States Details
University of Utah Clinical Trials Office SC - CTL019B2205J Salt Lake City Utah 84108 United States Details
Novartis Investigative Site Parkville Victoria 3052 Australia Details
Novartis Investigative Site Wien A 1090 Austria Details
Novartis Investigative Site Gent 9000 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 1X8 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1C5 Canada Details
Novartis Investigative Site Paris 10 Cedex 10 75475 France Details
Novartis Investigative Site Paris 75019 France Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Kyoto 606 8507 Japan Details
Novartis Investigative Site Oslo 0424 Norway Details
Novartis Investigative Site Esplugues De Llobregat Barcelona 08950 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field